BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 12227369)

  • 1. Neuroblastoma screening in early life.
    Kerbl R; Urban CE; Ambros PF
    N Engl J Med; 2002 Sep; 347(11):852-4; author reply 852-4. PubMed ID: 12227369
    [No Abstract]   [Full Text] [Related]  

  • 2. Is the mass screening for neuroblastoma ineffective?
    Nishi M; Hanai J; Fujita K; Ichimiya H; Tanaka T; Hatae Y; Takeda T
    J Exp Clin Cancer Res; 2003 Dec; 22(4):673-6. PubMed ID: 15053313
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuroblastoma screening in early life.
    Collins MH
    N Engl J Med; 2002 Sep; 347(11):852-4; author reply 852-4. PubMed ID: 12227370
    [No Abstract]   [Full Text] [Related]  

  • 4. Screening for neuroblastoma (NB) in North America: the Quebec Project.
    Woods WG; Lemieux B; Leclerc JM; Bernstein ML; Brisson L; Brossard J; Brodeur GM; Look AT; Robison LL; Shuster JJ
    Prog Clin Biol Res; 1994; 385():377-82. PubMed ID: 7972234
    [No Abstract]   [Full Text] [Related]  

  • 5. Treatment complications in children diagnosed with neuroblastoma during a screening program.
    Barrette S; Bernstein ML; Leclerc JM; Champagne MA; Samson Y; Brossard J; Woods WG
    J Clin Oncol; 2006 Apr; 24(10):1542-5. PubMed ID: 16575005
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A halt to neuroblastoma screening in Japan.
    Tsubono Y; Hisamichi S
    N Engl J Med; 2004 May; 350(19):2010-1. PubMed ID: 15128908
    [No Abstract]   [Full Text] [Related]  

  • 7. Neuroblastoma screening in early life.
    Suita S
    N Engl J Med; 2002 Sep; 347(11):852-4; author reply 852-4. PubMed ID: 12226161
    [No Abstract]   [Full Text] [Related]  

  • 8. Health and economic benefits of well-designed evaluations: some lessons from evaluating neuroblastoma screening.
    Soderstrom L; Woods WG; Bernstein M; Robison LL; Tuchman M; Lemieux B
    J Natl Cancer Inst; 2005 Aug; 97(15):1118-24. PubMed ID: 16077069
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Children may not benefit from neuroblastoma screening at 1 year of age. Updated results of the population based controlled trial in Germany.
    Schilling FH; Spix C; Berthold F; Erttmann R; Sander J; Treuner J; Michaelis J
    Cancer Lett; 2003 Jul; 197(1-2):19-28. PubMed ID: 12880955
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mass screening for neuroblastoma at 6 months of age.
    Miura Y; Kami M; Tsubokura M; Takei N; Komatsu T
    Lancet; 2008 Aug; 372(9636):372-3; author reply 373. PubMed ID: 18675685
    [No Abstract]   [Full Text] [Related]  

  • 11. Neuroblastoma screening for children: delay, repeat, or delete?
    Kerbl R; Urban CE; Ambros IM; Ambros PF
    Med Pediatr Oncol; 1998 Aug; 31(2):111-2. PubMed ID: 9680938
    [No Abstract]   [Full Text] [Related]  

  • 12. Population-based and controlled study to evaluate neuroblastoma screening at one year of age in Germany: interim results.
    Schilling FH; Berthold F; Erttmann R; Michaelis J; Spix C; Sander J; Schwarz K; Treuner J
    Med Pediatr Oncol; 2000 Dec; 35(6):701-4. PubMed ID: 11107150
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Report of the 1998 Consensus Conference on Neuroblastoma Screening.
    Med Pediatr Oncol; 1999 Oct; 33(4):357-9. PubMed ID: 10491542
    [No Abstract]   [Full Text] [Related]  

  • 14. Evaluation of the results of neuroblastoma screening at six months of age.
    Tsuchida Y; Ikeda H; Shitara T; Tanimura M
    Med Pediatr Oncol; 2000 Jan; 34(1):80-1. PubMed ID: 10611599
    [No Abstract]   [Full Text] [Related]  

  • 15. Incidence of neuroblastoma after a screening program.
    Barrette S; Bernstein ML; Robison LL; Samson Y; Brossard J; Weitzman S; Woods WG
    J Clin Oncol; 2007 Nov; 25(31):4929-32. PubMed ID: 17971590
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neuroblastomas that might benefit from mass screening at 6 months of age in Japan.
    Kaneko Y
    Pediatr Blood Cancer; 2007 Feb; 48(2):245-6; author reply 247. PubMed ID: 16652345
    [No Abstract]   [Full Text] [Related]  

  • 17. Substitute "prostate cancer" for "neuroblastoma"?
    Woods WG
    J Clin Oncol; 2002 Mar; 20(5):1154-5. PubMed ID: 11870152
    [No Abstract]   [Full Text] [Related]  

  • 18. Mother's attitudes towards the mass screening of neuroblastoma.
    Nishi M; Miyake H; Takasugi N; Sato Y; Hanai J; Takeda T
    Acta Paediatr Jpn; 1989 Apr; 31(2):166-70. PubMed ID: 2516695
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Screening for neuroblastoma: the final chapters.
    Woods WG
    J Pediatr Hematol Oncol; 2003 Jan; 25(1):3-4. PubMed ID: 12544765
    [No Abstract]   [Full Text] [Related]  

  • 20. Outcome of infants with neuroblastoma detected by mass screening and surgically treated in Shiga Prefecture, Japan: what is the role of surgery?
    Hase T; Ohta S; Tani T; Mizukuro T; Mekata E; Naitoh H; Shimadera S; Fujino S; Taga T
    Pediatr Surg Int; 2002 Sep; 18(5-6):289-94. PubMed ID: 12415341
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.